DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1003914
Title:
Vaccination with Dendritic Cell Myeloma Fusions in Conjuction with Stem Cell Transplantation and PD-1 Blockade
Corporate Author:
Beth Israel Deaconess Medical Center Boston United States
Report Date:
2015-07-01
Abstract:
In this project, we conducted a clinical trial in which patients with multiple myeloma were treated with an anti-PD1 antibody CT-011 alone Cohort 1 and in conjunction with a dendritic cellmyeloma fusion cell vaccine Cohort 2 following autologous transplantation. The goal ofthe project was to determine the effect of CT-011 alone, and in conjunction with a DCmyeloma fusion cell vaccine, to stimulate effective anti-tumor immunity and disease response.
Descriptive Note:
Technical Report,01 May 2014,30 Apr 2015
Pages:
0025
Distribution Statement:
Approved For Public Release;
File Size:
0.61MB
